These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27995324)

  • 1. HLA epitope matching in pediatric renal transplantation.
    Sypek MP; Hughes P; Kausman JY
    Pediatr Nephrol; 2017 Oct; 32(10):1861-1869. PubMed ID: 27995324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel aspects of epitope matching and practical application in kidney transplantation.
    Lim WH; Wong G; Heidt S; Claas FHJ
    Kidney Int; 2018 Feb; 93(2):314-324. PubMed ID: 29061333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA Epitope Matching in Kidney Transplantation: An Overview for the General Nephrologist.
    Sypek M; Kausman J; Holt S; Hughes P
    Am J Kidney Dis; 2018 May; 71(5):720-731. PubMed ID: 29246419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical evaluation of a possible role of HLA epitope matching in kidney transplantation.
    Kumru Sahin G; Unterrainer C; Süsal C
    Transplant Rev (Orlando); 2020 Apr; 34(2):100533. PubMed ID: 32007300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
    Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
    Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
    Bosch A; Llorente S; Diaz JA; Salgado G; López M; Boix F; López-Hernández R; González-Soriano MJ; Campillo JA; Moya-Quiles MR; Perez-Lopez N; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Hum Immunol; 2012 May; 73(5):522-5. PubMed ID: 22425738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long and winding road towards epitope matching in clinical transplantation.
    Kramer CSM; Israeli M; Mulder A; Doxiadis IIN; Haasnoot GW; Heidt S; Claas FHJ
    Transpl Int; 2019 Jan; 32(1):16-24. PubMed ID: 30341790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation.
    Kramer CSM; Roelen DL; Heidt S; Claas FHJ
    HLA; 2017 Jul; 90(1):5-16. PubMed ID: 28378521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope analysis of HLA-DQ antigens: what does the antibody see?
    Tambur AR; Rosati J; Roitberg S; Glotz D; Friedewald JJ; Leventhal JR
    Transplantation; 2014 Jul; 98(2):157-66. PubMed ID: 25003284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
    Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
    Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA Epitopes: The Targets of Monoclonal and Alloantibodies Defined.
    El-Awar N; Jucaud V; Nguyen A
    J Immunol Res; 2017; 2017():3406230. PubMed ID: 28626773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies.
    Duquesnoy RJ; Marrari M
    Curr Opin Organ Transplant; 2009 Aug; 14(4):403-9. PubMed ID: 19417654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eplet incompatibility in pediatric renal transplantation.
    Rãchişan AL; Dubois V; Ranchin B; Sellier-Leclerc AL; Bertholet Thomas A; Cochat P; Bacchetta J
    Pediatr Transplant; 2020 Sep; 24(6):e13721. PubMed ID: 32388894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time is life: EpAssistant - a new tool for the automatic identification of anti-HLA antibody epitope specificity in transplant programs.
    Aita KSU; Monte SJH; Silva AS; Moita Neto JM; Vieira RS; Machado VP; Sousa LCDM
    Transpl Immunol; 2018 Dec; 51():1-5. PubMed ID: 30081185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.
    Bezstarosti S; Bakker KH; Kramer CSM; de Fijter JW; Reinders MEJ; Mulder A; Claas FHJ; Heidt S
    Front Immunol; 2021; 12():800946. PubMed ID: 35154076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
    Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
    Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the ElliPro epitope predictor program in defining the repertoire of HLA-ABC eplets.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2017; 78(7-8):481-488. PubMed ID: 28336309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of epitope mismatch load in kidney transplantation: A multicentre study.
    Daniëls L; Naesens M; Bosmans JL; Abramowicz D; Nagler E; Van Laecke S; Peeters P; Kuypers D; Emonds MP
    Transpl Immunol; 2018 Oct; 50():55-59. PubMed ID: 29908316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.